Search | WHO COVID-19 Research Database

Pediatric intrathecal baclofen management during the COVID-19 pandemic in the US and Canada.

Thomas, Sruthi P; Hardesty, Christina K; Buxton, Kristin A; Collins, Andrew B; Pruente, Jessica; Pham, Kelly L D; Sheriko, Jordan; McClanahan, M Elise; Inanoglu, Didem; Srinivasan, Rajashree; Ridnour, Laura; Cooper, Robert; Khurana, Seema; Network, The Pediatric Itb.

J Pediatr Rehabil Med ; 13(3): 379-384, 2020.

Article in English | MEDLINE | ID: covidwho-949028

ABSTRACT

The COVID-19 pandemic has been a challenge to healthcare systems around the world. Within pediatric rehabilitation medicine, management of intrathecal baclofen has been particularly challenging. This editorial reviews how programs in the US and Canada coped with the quickly changing healthcare environment and how we can learn from this pandemic to be prepared for future crises.

Subject(s)

Baclofen/administration & dosage , COVID-19/epidemiology , Muscle Spasticity/drug therapy , Pandemics , Child , Comorbidity , Humans , Injections, Spinal , Muscle Relaxants, Central/administration & dosage , Muscle Spasticity/epidemiology , SARS-CoV-2 , Treatment Outcome

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL